Fig. 4.
Progression-free survival (PFS, A) and overall survival (OS, B) according to disease response to weekly gemcitabine-docetaxel treatment. PR, partial response; SD, stable disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.